Research: New & Noteworthy

Large Genetic Study Could Improve Endometrial Cancer Diagnosis and Treatment

An analysis of endometrial cancers reveals genetic information that should improve diagnosis and guide treatments for women with an aggressive form of the disease.

Pictured: Douglas Levine

Research Suggests a New Approach for Overcoming Resistance to a Targeted Therapy for Prostate Cancer

Research suggests that a new drug could be effective in patients with prostate cancer who develop resistance to the targeted therapy enzalutamide.

Pictured: Charles Sawyers

Pictured: Isabelle Rivière, Michel Sadelain & Renier Brentjens

Cell-Based Immune Therapy Shows Promise in Leukemia Patients

Memorial Sloan-Kettering researchers have used genetically modified immune cells to eradicate cancer in five patients with acute lymphoblastic leukemia.

Pictured: Isabelle Rivière, Michel Sadelain & Renier Brentjens

New Molecule Targets Proteins Inside Cancer Cells

Scientists from Memorial Sloan-Kettering have collaborated on the discovery of a unique monoclonal antibody, called ESK1, that appears to be effective at targeting and destroying several types of cancer cells.

Pictured: ESK1 Monoclonal Antibody

Researchers Identify Key Element of Nerve Cell Development

Researchers have clarified the process by which developing nerve cells are directed to specialize into distinct parts.

Pictured: Neurons

Study Clarifies How Bladder Cancer Treatment Works

Researchers have shed light on how an important treatment for early-stage bladder cancer enters cancer cells to eradicate them.

Pictured: BCG

Study Reveals Immune Response as Potential Biomarker to Predict Recurrence of Lung Cancer

A team from Memorial Sloan-Kettering has found that the makeup of immune cells in a lung tumor and in tissue surrounding a tumor can predict whether the cancer will recur after surgery.

Pictured: Prasad Adusumilli

New Findings Clarify How Kidney Cancer Spreads to Distant Organs

Scientists have identified genes and biological mechanisms that one day could be targeted with drugs to stop kidney cancer from spreading to the bone, brain, or other organs.

Pictured: X-ray Image

New Technique Could Make Cell-Based Immune Therapies for Cancer Safer and More Effective

Memorial Sloan-Kettering researchers have reported a new method that could allow the development of more-specific, cell-based therapies for cancer.

Pictured: Michel Sadelain

Study Suggests New Ways of Manipulating Immune System to Treat Autoimmune Diseases and Cancer

Recent findings by Memorial Sloan-Kettering immunologists might one day pave the way for new strategies to control a range of diseases, including autoimmune disorders and cancer.

Pictured: Ming Li

About Our Research

Research Programs & Departments

Sloan-Kettering Institute Programs

Clinical Research

Memorial Hospital Research

Extramural Collaborations

Collaborative Research Centers

Research Support

Pre- & Postdoctoral Training

Career Opportunities

Research: New & Noteworthy

On Cancer

Center News

Subscribe to Our E-newsletter

About Us

For Adult Patients

For Pediatric Patients

For Researchers

For Healthcare Professionals

Education & Training